Form 4: Charles River Laboratories Director Acquires Shares and Stock Options
SEC Form 4 Filing
George Massaro, a director at Charles River Laboratories, recently acquired shares and stock options in the company.
Summary
- On May 13, 2024, George Massaro, a director of Charles River Laboratories International, Inc., acquired 559 shares of common stock at a price of $228.41 per share.
- Following this transaction, Massaro directly owns 6,187 shares of common stock.
- Massaro also acquired 1,311 stock options with an exercise price of $228.41, which become exercisable on the earlier of May 13, 2025, or the business day prior to the company's next annual meeting of shareholders.
- These options expire on May 13, 2034.
- The unvested restricted stock units vest upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions, which carries a neutral sentiment.
Industry Context
This filing reflects routine transactions by company insiders, which are common and legal. It provides transparency into the trading activities of company leadership.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder confidence, as it signals that a director is investing in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 05/13/2024 | Date of transaction: Acquisition of common stock and stock options. |
| 05/13/2025 | Date stock options become exercisable (or the business day prior to the Company's next annual meeting of shareholders). |
| 05/13/2034 | Expiration date of the stock options. |
| 05/15/2024 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.